37 results on '"Solary, E."'
Search Results
2. The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development
3. Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution
4. cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation
5. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
6. Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes
7. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases
8. Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFNα treatment
9. JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma
10. A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
11. Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia
12. An evolutionary perspective on chronic myelomonocytic leukemia
13. JAK2V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms
14. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells
15. The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism
16. Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth
17. Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum
18. Caspase-10 involvement in cytotoxic drug-induced apoptosis of tumor cells
19. Mitochondria in hematopoiesis and hematological diseases
20. Cellular localisation of Survivin: impact on the prognosis in colorectal cancer
21. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
22. Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon α-2b for the treatment of chronic myelogenous leukemia patients in chronic phase
23. Early increase in DcR2 expression and late activation of caspases in the platelet storage lesion
24. Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML
25. Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes
26. Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies
27. A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes
28. Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms
29. Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis
30. Prolonged remission and autologous recovery in two patients with chronic myelogenous leukemia after graft failure of allogeneic bone marrow transplantation
31. Proteases, proteolysis, and apoptosis
32. Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients
33. Erratum: The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development
34. Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B
35. Peripheral blood stem cell transplantation in a multiple myeloma patient with end-stage renal failure
36. Intracellular redistribution of procaspases during TPA-induced differentiation of U937 human leukemic cells
37. Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.